Long-acting GLP-1 drug TE-8105, developed by Taiwan biotech Immunwork, confirmed a five-day plasma half-life in first-in-human trials using a dual fatty acid bundle approach not used by any approved ...
Everyday Health on MSN
Drugmaker to Offer Early Access to Experimental GLP-1 Retatrutide
The drugmaker said it would accept requests for early access to its experimental drug for some adults with severe obesity.
Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She’s a certified sleep science coach and ...
Two people have been arrested following a shooting in Virginia Beach last Friday afternoon. Link: https://www.wavy.com/news/local-news/hampton/flames-destroy-home-in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results